The Cigna Group
306.95USD
-8.9300 (-2.83%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CI.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $7.51▼ | $7.62 | 2 | 2 |
| Next quarter | $7.42▲ | $7.39 | 1 | 2 |
| Current year | $30.51▲ | $30.41 | 3 | 1 |
| Next year | $33.49▲ | $33.48 | 5 | 4 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $7.6 | $7.78 | +0.18 (+2.4%) |
| 2026-03-31 | $7.61 | $7.79 | +0.18 (+2.4%) |
| 2025-12-31 | $7.88 | $8.08 | +0.20 (+2.5%) |
| 2025-09-30 | $7.64 | $7.83 | +0.19 (+2.5%) |
355 ratings from 37 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Overweight | $346 $370 | Oct 2, 2026 |
| RBC Capital | Reiterated | Outperform | $337 | Oct 1, 2026 |
| Jefferies | Downgraded from Buy | Hold | $336 $307 | Aug 4, 2026 |
| Raymond James | Downgraded from Strong Buy | Outperform | $350 $320 | Aug 3, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $305 $307 | Jul 31, 2026 |
| Guggenheim | Maintained | Buy | $338 $361 | Jul 31, 2026 |
| Barclays | Maintained | Equal-Weight | $304 $310 | Jul 31, 2026 |
| Bernstein | Maintained | Outperform | $371 $381 | Jul 9, 2026 |
| Mizuho | Maintained | Outperform | $330 $340 | Jun 8, 2026 |
| Barclays | Downgraded from Overweight | Equal-Weight | $310 $304 | May 26, 2026 |
| UBS | Maintained | Buy | $375 $400 | May 22, 2026 |
| Morgan Stanley | Maintained | Overweight | $355 $361 | May 20, 2026 |
| Deutsche Bank | Downgraded from Buy | Hold | $303 $302 | May 20, 2026 |
| Bernstein | Maintained | Outperform | $358 $371 | May 5, 2026 |
| Guggenheim | Maintained | Buy | $334 $338 | May 4, 2026 |
| RBC Capital | Maintained | Outperform | $333 $337 | May 1, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $325 $340 | May 1, 2026 |
| Barclays | Maintained | Overweight | $303 $310 | May 1, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $300 $305 | May 1, 2026 |
| Jefferies | Maintained | Buy | $333 $330 | Apr 20, 2026 |
| Bernstein | Upgraded from Market Perform | Outperform | $307 $358 | Mar 12, 2026 |
| Piper Sandler | Reiterated | Overweight | $374 $370 | Mar 3, 2026 |
| Truist Securities | Reiterated | Buy | $320 $350 | Feb 17, 2026 |
| TD Cowen | Maintained | Buy | $333 $338 | Feb 9, 2026 |
| RBC Capital | Maintained | Outperform | $344 $333 | Feb 6, 2026 |
59 filings from 24 insiders · 14 buy / 5 sell over 6m
Officers and directors of CI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Neville EverettOfficer, See Remarks | Sell | 617 | $284.05 | $175k | Sep 3, 2026 |
| Evanko Brian COfficer, See Remarks | GrantEmployee Stock Option (Right to Buy) | 6.7k | — | — | Sep 1, 2026 |
| Evanko Brian COfficer, See Remarks | Grant | 3.1k | — | — | Sep 1, 2026 |
| Kurian GeorgeDirector | GrantPhantom Stock Units | 108.664 | $276.08 | $30k | Aug 31, 2026 |
| JONES NICOLE S.Officer | Sell | 2.7k | $279.61 | $749k | Aug 18, 2026 |
| JONES NICOLE S.Officer | Exercise | 15.3k | $192.02 | $2.95M | Aug 5, 2026 |
| JONES NICOLE S.Officer | Sell | 19.4k | $276.27 | $5.37M | Aug 4, 2026 |
| KATES JAMIE GOfficer | Exercise | 899 | $152.89 | $137k | Jun 12, 2026 |
| KATES JAMIE GOfficer | Sell | 899 | $298.61 | $268k | Jun 12, 2026 |
| CORDANI DAVID MChief Executive Officer | Exercise | 212.5k | $149.14 | $36.21M | May 13, 2026 |
| CORDANI DAVID MChief Executive Officer | Sell | 201.9k | $286.83 | $59.11M | May 12, 2026 |
| KURIAN GEORGEDirector | Grant | 782 | — | — | Apr 22, 2026 |
| MCCLELLAN MARK BDirector | Grant | 782 | — | — | Apr 22, 2026 |
| ROSS KIMBERLY ADirector | Grant | 782 | — | — | Apr 22, 2026 |
| OZUAH PHILLIPDirector | Grant | 782 | — | — | Apr 22, 2026 |
| HATHI NEESHADirector | Grant | 782 | — | — | Apr 22, 2026 |
| HENNIGAN MICHAEL JDirector | Grant | 782 | — | — | Apr 22, 2026 |
| WISEMAN ERIC CDirector | Grant | 782 | — | — | Apr 22, 2026 |
| MAZZARELLA KATHLEEN M.Director | Grant | 782 | — | — | Apr 22, 2026 |
| FOSS ERIC J.Director | Grant | 782 | — | — | Apr 22, 2026 |
No analyst notes on CI yet.
Analyst Ratings
24 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 12 | 7 | 0 | 0 | Buy2.08 |
| 1 mo ago | 6 | 12 | 6 | 0 | 0 | Buy2.00 |
| 2 mo ago | 6 | 13 | 5 | 0 | 0 | Buy1.96 |
| 3 mo ago | 5 | 15 | 4 | 0 | 0 | Buy1.96 |
Members whose judged calls on CI have played out most reliably.
No settled calls on CI yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice